Heterocyclic topoisomerase poisons
AssigneeRutgers, The State University of New Jersey
InventorsEdmond J. LaVoie, Jung Sun Kim, Leroy Fong Liu
Life of this patent
Estimating the term…
Loading patent…
AssigneeRutgers, The State University of New Jersey
InventorsEdmond J. LaVoie, Jung Sun Kim, Leroy Fong Liu
Estimating the term…
The invention provides compounds of formula I: 1 wherein R1 to R5 have any of the values defined in the specification, as well as pharmaceutically acceptable salts of the compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds, compositions, or salts to treat cancer. In embodiments, R4 and R5 taken together can be a 3, 4, or 5 membered saturated or unsaturated chain comprising members selected from the group consisting of non-peroxide oxygen, sulfur, N(X), and carbon, optionally substituted by oxo; wherein each X is independently absent or is H, O, (C1-C4)alkyl, phenyl or benzyl; and wherein at least one of the chain members is an N—H group.
A therapeutic method comprising inhibiting cancer cells by administering to a mammal in need of such therapy, an amount of a compound of formula I:
A method comprising inhibiting cancer cells by contacting said cancer cells with an effective amount of a compound of formula I:
Dependencies are inferred from the claim text.